Hemodynamic changes and evaluation during hypoxic-ischemic encephalopathy and therapeutic hypothermia

Area of Science:

• Neonatal medicine
• Cardiology
• Neurology

Background:

• Hypoxic-ischemic encephalopathy (HIE) is characterized by multiorgan damage, with cardiovascular and hemodynamic alterations significantly contributing to brain injury.
• The immature myocardium is susceptible to asphyxia, leading to bradycardia and reduced contractile function, further complicated by pulmonary hypertension.

Purpose of the Study:

• To review the cardiovascular effects of HIE and its treatment with therapeutic hypothermia.
• To highlight monitoring strategies and evidence-based management for cardiac dysfunction in HIE.

Main Methods:

• Review of existing literature on HIE, cardiac dysfunction, and therapeutic hypothermia.
• Discussion of monitoring techniques including near-infrared spectroscopy, echocardiography, and electrocardiography.
• Analysis of current and investigational pharmacological treatments.

Main Results:

• Asphyxia causes myocardial damage and ventricular dysfunction, exacerbated by pulmonary hypertension.
• Therapeutic hypothermia, while beneficial for HIE, can induce bradycardia and vasoconstriction, potentially offering cardioprotection.
• Rewarming may increase cardiac metabolism and output, necessitating close monitoring.

Conclusions:

• Management of HIE requires a comprehensive approach addressing the patient's physiological status and cardiac function.
• Targeted echocardiography and evidence-based treatments, including inotropes and vasopressors, are crucial.
• Further investigation into agents like melatonin and magnesium is warranted.